Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

61
Impulsivity, Attention Deficits and Addiction: Perspectives on Concepts, Diagnoses, and Treatment Christian G. Schütz MD PhD MPH Associate Professor Institute of Mental Health, Dep. of Psychiatry Email: [email protected] Medical Manager The Burnaby Centre for Mental Health & Addiction

description

This is a presentation that was given at the Lost in Translation 2013: Exploring the Origins of Addiction conference, that took place on March 25 - 26, 2013 in Vancouver, British Columbia, Canada

Transcript of Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

Page 1: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

Impulsivity, Attention Deficits and Addiction: Perspectives on Concepts,

Diagnoses, and Treatment

Christian G. Schütz MD PhD MPH Associate Professor Institute of Mental Health, Dep. of Psychiatry Email: [email protected] Medical Manager The Burnaby Centre for Mental Health & Addiction

Page 2: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Overview •  introduction and context •  etiological considerations •  attention deficits and impulsivity •  interventions considerations •  summary

Page 3: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Overview •  introduction and context •  etiological considerations •  attention deficits and impulsivity •  interventions considerations •  summary

Page 4: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment
Page 5: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

The Four Quadrant Framework for Co-Occurring Disorders

Less severe mental disorder/

less severe substance

abuse disorder

More severe mental disorder/

less severe substance

abuse disorder

More severe mental disorder/

more severe substance

abuse disorder

Less severe mental disorder/

more severe substance

abuse disorder

High severity

Page 6: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

Mood disorders

Page 7: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

Psychosis

Page 8: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

Addiction

Page 9: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

Anxiety disorders

Page 10: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

Adult ADHD Self-Report Scale

ADHD screener >50%

18 questions Adler et al.

Page 11: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Page 12: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Overview •  introduction and context •  etiological considerations •  attention deficits and impulsivity •  interventions considerations •  summary

Page 13: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

genes environment

Page 14: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS www.thelancet.com Published online February 28, 2013

Page 15: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS www.thelancet.com Published online February 28, 2013

Page 16: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Page 17: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS www.thelancet.com Published online February 28, 2013

Consistent with a pleiotropic role of CACNA1C variants , neuro-imaging studies have documented effects of voltage gated calcium channels on a range of structural and functional brain phenotypes, including circuitry involved in: •  emotion processing, •  executive function, •  attention, and •  memory.

Page 18: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

genes environment

Page 19: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Childhood predictors of adult ADHD: Results from the WHO World Mental Health (WMH) Survey Initiative Lara et al. An average of 50% of children with ADHD continued to meet DSM-IV criteria for ADHD as adults. Persistence was strongly related to: •  attentional plus hyperactive type, •  symptom severity, •  comorbid major depressive disorder, •  high comorbidity, •  paternal anxiety-mood disorder •  parental antisocial personality disorder. Childhood adversity predicted ADHD, but not persistence into adulthood

Page 20: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

Lifetime trauma experience

Page 21: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

Stahl  Essential  Psychopharmacology    

Page 22: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

*  

*  

*  

*  

Page 23: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

*  

*  

*  

*  

Page 24: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

*  

*  

*  

*  

Page 25: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

Stahl  Essential  Psychopharmacology    

ADHD  Addiction  Bipolar  Schizophrenia  

Page 26: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

SJ  Lupien,  BS  McEwen,  MR.  Gunnar  and  C  Heim.  Nature  Reviews  Neuroscience  10,  434-­‐445  (2009)  adapted  

Page 27: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

SJ  Lupien,  BS  McEwen,  MR.  Gunnar  and  C  Heim.  Nature  Reviews  Neuroscience  10,  434-­‐445  (2009)  adapted  

Page 28: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

BL  Thompson,  P  Levitt  &  GD  Stanwood  Nature  Reviews  Neuroscience  10,  303-­‐312  (April  2009)    

Page 29: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

| | | | | | | | | | | | | | | | |

Substance use disorder

Page 30: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

SJ  Lupien,  BS  McEwen,  MR.  Gunnar  and  C  Heim.  Nature  Reviews  Neuroscience  10,  434-­‐445  (2009)  adapted  

Page 31: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

•     The  prefrontal  cortex  subserves  conscious  decision  making  (thoughtful  reflective  response).    

•     PFC  is  the  brain  region  most  sensitive  to  detrimental  effects  of  stress  exposure.  

•     Even  mild  acute  uncontrollable  stress  can  cause  a  dramatic  loss  of  cognitive  abilities    

•     Prolonged  stress  exposure  causes  architectural  changes  in  prefrontal  dendrites  

AFT  Arnstein  Nature  Reviews  Neuroscience  10,  410-­‐422  (June  2009)  

Page 32: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

genes

Multi-causality and Pleiotropy is the standard

Page 33: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Overview •  introduction and context •  etiological considerations •  impulsivity and attention deficits •  interventions considerations •  summary

Page 34: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Questionnaire Behavioral Tests

Page 35: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Barratt Impulsivity Scale-11 (BIS) Patton et al., 1995 •  motor impulsivity •  non-planning •  attentional impulsivity 30 items, likert scale

Page 36: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

UPPS-P Impulsive Behavior Scale Perales et al. 2009 •  lack of premeditation •  lack of perseverance •  “negative” urgency •  "positive” urgency •  sensation-seeking

59-item likert scale

Page 37: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

REVIEW: Impulsivity as a determinant and consequence of drug use: a review of underlying processes Harriet De Wit (2008)

Page 38: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

REVIEW: Impulsivity as a determinant and consequence of drug use: a review of underlying processes Harriet De Wit (2008)

Page 39: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

REVIEW: Impulsivity as a determinant and consequence of drug use: a review of underlying processes Harriet De Wit (2008)

Page 40: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS Tüscher et al 2012

fronto-parietal–pre-motor circuits

prefrontal–striatal

Page 41: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

REVIEW: Impulsivity as a determinant and consequence of drug use: a review of underlying processes Harriet De Wit (2008)

Page 42: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

REVIEW: Impulsivity as a determinant and consequence of drug use: a review of underlying processes Harriet De Wit (2008)

Page 43: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Latent Discounting

Peters 2011

Page 44: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

    UPPS+P    

BIS    

 Total  

Neg  Urgency  

(lack  of)  Premed  

(lack  of)  Preserve  

Sens  Seeking  

Pos  Urgency  

 Total  

 A>en?on  

 Motor  

Non-­‐Planning    

 

DERS  Total  

Acceptance  Goals  

Impulse  Awareness  

Strategy  Clarity  

.57* .11 .58* .54* .69** .37 .44  

.66** .27 .63** .69** .47 .53* .47  

.53* .28 .42 .17 .73*** .30 .48*  

.52* .21 .36 .13 .70** .46 .64*  

-.33 -.54* -.11 .15 -.01 -.52* -.41  

.55* .23 .59* .55* .36 .45 .38  

.15 .15 -.21 .01 .22 .09 .43  

.12 .04 -.09 .13 .09 .06 .34  

-.09 -.01 -.30 -.03 -.06 -.13 .08  

.27 .28 - .41 -.02 .35 .23 .58*  

DDT  $100  $1000  

   

.47 -.09  

.24 -.22  

.24 .08  

.13 -.14  

.37 -.10  

.41 .03  

-.33 -.17  

-.30 -.17  

-.28 -.07  

-.35 -.21  

SST   -.34 -.06 -.21 -.26 -.32 -.20 .67** .48* .62** .65**

SWM   -.64**  

-.44  

-.38

 

-.41

 

-.35  

-.42  

-.17 -.19 -.04

-.18  

    UPPS+P    

BIS    

 Total  

Neg  Urgency  

(lack  of)  Premed  

(lack  of)  Preserve  

Sens  Seeking  

Pos  Urgency  

 Total  

 A>en?on  

 Motor  

Non-­‐Planning    

 

DERS  Total  

Acceptance  Goals  

Impulse  Awareness  

Strategy  Clarity  

.57* .11 .58* .54* .69** .37 .44  

.66** .27 .63** .69** .47 .53* .47  

.53* .28 .42 .17 .73*** .30 .48*  

.52* .21 .36 .13 .70** .46 .64*  

-.33 -.54* -.11 .15 -.01 -.52* -.41  

.55* .23 .59* .55* .36 .45 .38  

.15 .15 -.21 .01 .22 .09 .43  

.12 .04 -.09 .13 .09 .06 .34  

-.09 -.01 -.30 -.03 -.06 -.13 .08  

.27 .28 - .41 -.02 .35 .23 .58*  

DDT  $100  $1000  

   

.47 -.09  

.24 -.22  

.24 .08  

.13 -.14  

.37 -.10  

.41 .03  

-.33 -.17  

-.30 -.17  

-.28 -.07  

-.35 -.21  

SST   -.34 -.06 -.21 -.26 -.32 -.20 .67** .48* .62** .65**

SWM   -.64**  

-.44  

-.38

 

-.41

 

-.35  

-.42  

-.17 -.19 -.04

-.18  

Chao 2013 DERS: Difficulties in emotional regulaton scale DDT: Delayed Disounting SST Stop Signal Task SWM: Spatial working memory UPPS+P

Page 45: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

REVIEW: Impulsivity as a determinant and consequence of drug use: a review of underlying processes Harriet De Wit (2008)

Page 46: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Subcomponents attention: Top down: Prefrontal Cortex: sustain, switch

divide inhibit distraction

Inferior temporal cortex: focus Posterior parietal association cortex: orienting

Page 47: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Overview •  introduction and context •  etiological considerations •  attention deficits and impulsivity •  interventions considerations •  summary

Page 48: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Page 49: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Mood stabilizers have been used extensively to treat impulsive disorders. Moderate efficacy in at least half of patients studied have been reported. Results differ across specific mood stabilizers. Positive data have been published for Valproate, Phenytoin, Carbamazepine, Topiramate and Lithium. (not for Gabapentin and Levotireacetam). Some positive results for atypical neuroleptics (Olanzapine, Aripiprazole, Quetiapine) and antidepressant (Bupropion) have been reported. Based on ADHD treatment Stimulants (Modafinil, Methylphenidate, Amphetamine) Atomoxetine, have lead to positive results in some patients. Cognitive Behavior Therapies, Dialectical Behavior Therapy and Contingency Management seem to be more promising psychotherapeutic approaches.

Symptom-targeted strategies appear to provide the best likelihood of success when using medications to improve the care of patients with personality disorders. Impulsivity appears to be the most consistent fundamentally disturbed behavior linking the spectrum of bipolar conditions, including those that present more as personality disorders or aberrations of temperament. Mood stabilizers have been used extensively to treat impulsive and aggressive disorders. Although most studies have limitations in design, moderate efficacy in at least half of patients studied has been reported. Results differ across drugs. More positive data have been published for valproate, although most are from open-label trials. The role of impulsive drug seeking is a major component of persistent drug abuse. Currently, therapies are at best of modest utility. More systematic studies of drugs and of psychological strategies are needed to address cues that trigger impulsive drug seeking. Naturalistic long-term studies indicate high rates of prescriptions of mood stabilizers for patients with borderline personality disorders. Cognitive therapies to enhance adherence to medication treatments are promising, but surprisingly poorly studied in systematic trials

Symptom-targeted strategies appear to provide the best likelihood of success when using medications to improve the care of patients with personality disorders. Impulsivity appears to be the most consistent fundamentally disturbed behavior linking the spectrum of bipolar conditions, including those that present more as personality disorders or aberrations of temperament. Mood stabilizers have been used extensively to treat impulsive and aggressive disorders. Although most studies have limitations in design, moderate efficacy in at least half of patients studied has been reported. Results differ across drugs. More positive data have been published for valproate, although most are from open-label trials. The role of impulsive drug seeking is a major component of persistent drug abuse. Currently, therapies are at best of modest utility. More systematic studies of drugs and of psychological strategies are needed to address cues that trigger impulsive drug seeking. Naturalistic long-term studies indicate high rates of prescriptions of mood stabilizers for patients with borderline personality disorders. Cognitive therapies to enhance adherence to medication treatments are promising, but surprisingly poorly studied in systematic trials

Symptom-targeted strategies appear to provide the best likelihood of success when using medications to improve the care of patients with personality disorders. Impulsivity appears to be the most consistent fundamentally disturbed behavior linking the spectrum of bipolar conditions, including those that present more as personality disorders or aberrations of temperament. Mood stabilizers have been used extensively to treat impulsive and aggressive disorders. Although most studies have limitations in design, moderate efficacy in at least half of patients studied has been reported. Results differ across drugs. More positive data have been published for valproate, although most are from open-label trials. The role of impulsive drug seeking is a major component of persistent drug abuse. Currently, therapies are at best of modest utility. More systematic studies of drugs and of psychological strategies are needed to address cues that trigger impulsive drug seeking. Naturalistic long-term studies indicate high rates of prescriptions of mood stabilizers for patients with borderline personality disorders. Cognitive therapies to enhance adherence to medication treatments are promising, but surprisingly poorly studied in systematic trials

Page 50: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

Bra

in (c

ell)

Glutamate GABA

Dopamine

Serotonin

Executive Control Reward/Motivation Emotional regulation

Beh

avio

r

Relapse Addiction Mood episode

Medication

Page 51: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

Psychosocial setting Psychotherapy

Env

ironm

ent Abstract

Information

Incentives

Trust/threat signals

Bra

in

Executive Control Reward/Motivation Emotional regulation

Beh

avio

r ADH Addiction Mood episode

Page 52: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

ECT, TMS, DBS..

Bra

in (a

nato

.)

DLPC OFPC Striatum VMPC Amygdala Insula

Executive Control Reward/Motivation Emotional regulation

Beh

avio

r

Relapse Addiction Mood episode

Page 53: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

Psy

chot

hera

py

Bra

in

Executive Control Reward/Motivation Emotional regulation

Beh

avio

r

ADHD Addiction Mood episode

Mindfulness, Grounding

CM SCT, GNG

CBT, DBT, ME

Page 54: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

SCT: Several researchers tried to improve trait self-control. Successful training generalized to other tasks. To this end, participants were asked to brush their teeth or use the computer mouse with the non-dominant hand, keep a good posture, avoid slang words, perform Stroop tasks, keep a financial diary, or adhere to study or exercise plans (Azor Hui et al., 2009; Gailliot, Plant, Butz, & Baumeister, 2007; Muraven, Baumeister, & Tice, 1999; Oaten & Cheng, 2006a, 2006b, 2007).

GNG: One program aimed at fostering response inhibition. In this study, participants completed an adapted Go/No-Go task. (Houben, Nederkoorn, Wiers, & Jansen, 2010)

Page 55: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

•     The  prefrontal  cortex  subserves  conscious  decision  making  (thoughtful  reflective  response).    

•     PFC  is  the  brain  region  most  sensitive  to  detrimental  effects  of  stress  exposure.  

•     Even  mild  acute  uncontrollable  stress  can  cause  a  dramatic  loss  of  cognitive  abilities    

•     Prolonged  stress  exposure  causes  architectural  changes  in  prefrontal  dendrites  

AFT  Arnstein  Nature  Reviews  Neuroscience  10,  410-­‐422  (June  2009)  

Page 56: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Overview •  introduction and context •  etiological considerations •  attention deficits and impulsivity •  interventions considerations •  summary

Page 57: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Overview •  introduction and context •  etiological considerations •  attention deficits and impulsivity •  interventions considerations •  summary

Page 58: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

engagement in meaningful activities and relationships

self organization, structuring, healthy living

TREATMENT: diagnosis versus syndrome (domain-specific) informed

PSYCHO- SOCIAL SETTING

Page 59: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

engagement in meaningful activities and relationships

self organization, structuring, healthy living

Contingency

Management

Cognitive

Behaviour

Avoidance

Training

PSYCHO- SOCIAL SETTING

SPECIFIC INTERVENTION

TREATMENT: diagnosis versus syndrome (domain-specific) informed

Page 60: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

engagement in meaningful activities and relationships

self organization, structuring, healthy living

Contingency

Management

Cognitive

Behaviour

Avoidance

Training

Evidence based:

PSYCHO- SOCIAL SETTING

SPECIFIC INTERVENTION

Medication

Regular systematic off-label

Page 61: Impulsivity, Attention Deficits, and Addiction - Perspectives on Diagnoses and Treatment

CGS

Thank you for your attention